Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $216000.0.

  • Ekso Bionics Holdings' Change in Account Payables rose 16708.07% to $216000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$152000.0, marking a year-over-year increase of 7831.67%. This contributed to the annual value of -$288000.0 for FY2024, which is 7796.48% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Change in Account Payables stood at $216000.0 for Q3 2025, which was up 16708.07% from -$565000.0 recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Change in Account Payables high stood at $1.8 million for Q4 2021, and its period low was -$882000.0 during Q2 2022.
  • For the 5-year period, Ekso Bionics Holdings' Change in Account Payables averaged around $526.32, with its median value being -$110000.0 (2023).
  • The largest annual percentage gain for Ekso Bionics Holdings' Change in Account Payables in the last 5 years was 128750.0% (2025), contrasted with its biggest fall of 32690.76% (2025).
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Change in Account Payables stood at $1.8 million in 2021, then tumbled by 66.57% to $602000.0 in 2022, then crashed by 209.63% to -$660000.0 in 2023, then skyrocketed by 62.58% to -$247000.0 in 2024, then surged by 187.45% to $216000.0 in 2025.
  • Its Change in Account Payables stands at $216000.0 for Q3 2025, versus -$565000.0 for Q2 2025 and $444000.0 for Q1 2025.